Affordable Access

Publisher Website

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.

Authors
Type
Published Article
Journal
Targeted Oncology
1776-260X
Publisher
Springer-Verlag
Publication Date
Volume
9
Issue
3
Pages
273–277
Identifiers
DOI: 10.1007/s11523-013-0299-0
PMID: 24218035
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments